Cooper ROE 2010-2024 | COO

Current and historical return on equity (ROE) values for Cooper (COO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Cooper ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-01-31 $0.29B $7.70B 3.86%
2023-10-31 $0.30B $7.55B 3.96%
2023-07-31 $0.28B $7.53B 3.75%
2023-04-30 $0.29B $7.38B 3.99%
2023-01-31 $0.38B $7.34B 5.26%
2022-10-31 $0.39B $7.18B 5.48%
2022-07-31 $0.43B $7.08B 6.15%
2022-04-30 $0.95B $7.01B 13.71%
2022-01-31 $0.94B $6.93B 14.01%
2021-10-31 $2.95B $6.94B 45.52%
2021-07-31 $2.92B $6.79B 51.24%
2021-04-30 $2.36B $6.16B 47.73%
2021-01-31 $2.25B $5.99B 52.29%
2020-10-31 $0.24B $3.83B 6.40%
2020-07-31 $0.28B $3.76B 7.57%
2020-04-30 $0.34B $3.63B 9.42%
2020-01-31 $0.45B $3.73B 12.51%
2019-10-31 $0.47B $3.63B 13.11%
2019-07-31 $0.45B $3.62B 12.84%
2019-04-30 $0.43B $3.54B 12.65%
2019-01-31 $0.37B $3.43B 11.13%
2018-10-31 $0.14B $3.31B 4.35%
2018-07-31 $0.13B $3.23B 4.02%
2018-04-30 $0.13B $3.19B 4.15%
2018-01-31 $0.18B $3.16B 5.66%
2017-10-31 $0.37B $3.18B 12.44%
2017-07-31 $0.35B $3.09B 11.98%
2017-04-30 $0.33B $2.94B 11.79%
2017-01-31 $0.30B $2.82B 10.88%
2016-10-31 $0.27B $2.70B 10.16%
2016-07-31 $0.25B $2.74B 9.29%
2016-04-30 $0.21B $2.75B 7.72%
2016-01-31 $0.19B $2.61B 7.33%
2015-10-31 $0.20B $2.67B 7.77%
2015-07-31 $0.20B $2.69B 7.60%
2015-04-30 $0.24B $2.62B 9.27%
2015-01-31 $0.26B $2.52B 10.02%
2014-10-31 $0.27B $2.59B 10.51%
2014-07-31 $0.30B $2.68B 11.71%
2014-04-30 $0.30B $2.56B 12.03%
2014-01-31 $0.29B $2.45B 12.14%
2013-10-31 $0.30B $2.42B 12.53%
2013-07-31 $0.31B $2.44B 13.47%
2013-04-30 $0.29B $2.34B 12.99%
2013-01-31 $0.27B $2.25B 12.51%
2012-10-31 $0.25B $2.21B 12.02%
2012-07-31 $0.23B $2.10B 11.69%
2012-04-30 $0.21B $2.04B 10.82%
2012-01-31 $0.19B $1.94B 10.09%
2011-10-31 $0.18B $1.94B 9.51%
2011-07-31 $0.17B $1.89B 9.37%
2011-04-30 $0.16B $1.81B 9.54%
2011-01-31 $0.13B $1.72B 8.03%
2010-10-31 $0.11B $1.67B 7.05%
2010-07-31 $0.09B $1.59B 6.04%
2010-04-30 $0.08B $1.54B 4.94%
2010-01-31 $0.10B $1.55B 6.43%
2009-10-31 $0.10B $1.54B 6.89%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.860B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00